Hologic (NASDAQ: HOLX), a medical imaging company, is recently trading down 71 cents to $20.22 in pre-open trading.

Soleil says: "downgrading HOLX from Buy to Hold following our confirmation from the FDA that the tentative date for Radiological Devices Panel (8.12.08) has been canceled-an action which reads negative for HOLX."

HOLX over all option implied volatility of 46 is above its 26-week average of 43 according to Track Data, suggesting larger price uncertainty.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com